Newsletter Subject

Could this Healthcare Stock really climb 895.15% in 2023?

From

markettickerpress.com

Email Address

editor@markettickerpress.com

Sent On

Thu, May 11, 2023 01:38 PM

Email Preheader Text

Earnings Alert. If you cannot see this email properly, please click --------------------------------

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Graphite versus Lithium - What Investors Should Know]( [See why graphite could be the "new lithium"]( --------------------------------------------------------------- May 11, 2023 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [146 Pounds of Graphite Needed for Each EV]( - not lithium - is the largest component of lithium-ion batteries used in electric vehicles. That's why 97 more graphite mines will be needed by 2035 just to keep up with battery demand for the $7 trillion EV market. [See who could benefit from skyrocketing graphite demand]( --------------------------------------------------------------- [Airsculpt Technologies, Inc.]( Symbol: [AIRS]( Recent Price: $5.04 Average Analyst Price Target: $6.38 (26.59%) Market Cap: $296.02M Last Year's EPS: -$0.01 Consensus EPS Forecast: $0.13 Expected Earnings Date: May 12 2023 Recent Analyst Action: Whit Mayo, analyst at SVB Securities, reiterates coverage on [Airsculpt Technologies, Inc. (AIRS)]( in the Healthcare sector with a Buy rating and a price target of $6.5 (1 month ago). [TipRanks.com]( also reports that [Airsculpt Technologies, Inc.]( currently has 4 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $6.38. The target pricing ranges from a high forecast of $8.00 down to a low forecast of $5.00. [Airsculpt Technologies, Inc. (AIRS)](’s last closing price was $5.04 which would put the average price target at 26.59% upside. Here are 3rd party ratings for [AIRS](: - TipRanks.com: Moderate Buy - TradingView.com: Neutral - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 48% (121 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Better Than Oil Stocks]( best way to profit from energy is NOT a stock... Rather, it's this little-known alternative investment. [CLICK HERE TO FIND OUT MORE]( --------------------------------------------------------------- [Vitesco Technologies Group AG]( Symbol: [VTSCF]( Recent Price: $59.28 Average Analyst Price Target: $83.35 (39.84%) Market Cap: $2.72B Last Year's EPS: $0.14 Consensus EPS Forecast: $0.78 Expected Earnings Date: May 12 2023 Recent Analyst Action: Alexandre Raverdy, analyst at Kepler Capital , reiterates coverage on [Vitesco Technologies Group AG (VTSCF)]( in the Industrial Goods sector with a Hold rating and a price target of $62.54 (6 days ago). [TipRanks.com]( also reports that [Vitesco Technologies Group AG]( currently has 9 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $83.35. The target pricing ranges from a high forecast of $115.83 down to a low forecast of $62.88. [Vitesco Technologies Group AG (VTSCF)](’s last closing price was $59.28 which would put the average price target at 39.84% upside. Here are 3rd party ratings for [VTSCF](: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: n/a - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- [Terran Orbital Corp]( Symbol: [LLAP]( Recent Price: $1.88 Average Analyst Price Target: $10.67 (467.55%) Market Cap: $268.28M Last Year's EPS: -$0.85 Consensus EPS Forecast: -$0.16 Expected Earnings Date: May 12 2023 Recent Analyst Action: Ronald Epstein, analyst at Bank of America Securities, reiterates coverage on [Terran Orbital Corp (LLAP)]( in the Technology sector with a Buy rating and a price target of $7.00 (1 month ago). [TipRanks.com]( also reports that [Terran Orbital Corp]( currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $10.67. The target pricing ranges from a high forecast of $15.00 down to a low forecast of $7.00. [Terran Orbital Corp (LLAP)](’s last closing price was $1.88 which would put the average price target at 467.55% upside. Here are 3rd party ratings for [LLAP](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Sell, Bottom 28% (179 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Trump was right about China!]( Recently China tested a hypersonic missile that can carry a nuke around the world. The good news is... Trump predicted this! And began partnering with a small laser company that's working to shoot down these missiles. [Get the name of the small company here ]( --------------------------------------------------------------- [Tempest Therapeutics]( Symbol: [TPST]( Recent Price: $2.06 Average Analyst Price Target: $20.50 (895.15%) Market Cap: $21.65M Last Year's EPS: -$1.18 Consensus EPS Forecast: -$0.64 Expected Earnings Date: May 12 2023 Recent Analyst Action: Joseph Pantginis, analyst at H.C. Wainwright, reiterates coverage on [Tempest Therapeutics (TPST)]( in the Healthcare sector with a Buy rating and a price target of $35.00 (1 week ago). [TipRanks.com]( also reports that [Tempest Therapeutics]( currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $20.50. The target pricing ranges from a high forecast of $35.00 down to a low forecast of $6.00. [Tempest Therapeutics (TPST)](’s last closing price was $2.06 which would put the average price target at 895.15% upside. Here are 3rd party ratings for [TPST](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 45% (113 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Palisade Bio]( Symbol: [PALI]( Recent Price: $1.59 Average Analyst Price Target: $5.00 (214.47%) Market Cap: $9.31M Last Year's EPS: -$13 Consensus EPS Forecast: -$0.72 Expected Earnings Date: May 12 2023 Recent Analyst Action: Naz Rahman, analyst at Maxim Group, reiterates coverage on [Palisade Bio (PALI)]( in the Healthcare sector with a Buy rating and a price target of $5.00 (1 month ago). [TipRanks.com]( also reports that [Palisade Bio]( currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $5.00. The target pricing ranges from a high forecast of $5.00 down to a low forecast of $5.00. [Palisade Bio (PALI)](’s last closing price was $1.59 which would put the average price target at 214.47% upside. Here are 3rd party ratings for [PALI](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Buy, Top 40% (99 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [#1 Stock for Energy Crisis (Buy Now for Just $8)]( the world suffers an oil shock… And gas prices rip higher… One tiny company could have the answer to the global energy crisis. It’s using AI to crack open the largest untapped energy source on the planet… 5X larger than the biggest oil field on Earth. [Act fast, this $8 stock could be moments away from appreciating considerably.]( --------------------------------------------------------------- [Invivyd]( Symbol: [IVVD]( Recent Price: $1.42 Average Analyst Price Target: $3.00 (111.27%) Market Cap: $129.94M Last Year's EPS: -$0.93 Consensus EPS Forecast: -$0.35 Expected Earnings Date: May 12 2023 Recent Analyst Action: Patrick Trucchio, analyst at H.C. Wainwright, reiterates coverage on [Invivyd (IVVD)]( in the Healthcare sector with a Buy rating and a price target of $5.00 (1 day ago). [TipRanks.com]( also reports that [Invivyd]( currently has 2 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $3.00. The target pricing ranges from a high forecast of $5.00 down to a low forecast of $1.00. [Invivyd (IVVD)](’s last closing price was $1.42 which would put the average price target at 111.27% upside. Here are 3rd party ratings for [IVVD](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 40% (99 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Evotec AG]( Symbol: [EVO]( Recent Price: $10.34 Average Analyst Price Target: $12.00 (16.05%) Market Cap: $3.20B Last Year's EPS: -$0.22 Consensus EPS Forecast: $0.13 Expected Earnings Date: May 12 2023 Recent Analyst Action: James Quigley, analyst at Morgan Stanley, reiterates coverage on [Evotec AG (EVO)]( in the Healthcare sector with a Hold rating and a price target of $12.00 (1 month ago). [TipRanks.com]( also reports that [Evotec AG]( currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $12.00. The target pricing ranges from a high forecast of $12.00 down to a low forecast of $12.00. [Evotec AG (EVO)](’s last closing price was $10.34 which would put the average price target at 16.05% upside. Here are 3rd party ratings for [EVO](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 45% (113 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [AI Getting Close to Thinking Like Humans]( experts working with neuroscientists have created the world's first Artificial Intelligence Network Operating System. AI can now process information like the human brain and understand the world the way humans do. [See the Young Company Behind This Revolutionary Advancement]( --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software

Marketing emails from markettickerpress.com

View More
Sent On

04/03/2024

Sent On

03/03/2024

Sent On

03/03/2024

Sent On

03/03/2024

Sent On

02/03/2024

Sent On

02/03/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.